Stibbe advises major pharmaceutical company

Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. We also advised the company on the information policy and advertising towards healthcare professionals concerning competing products in the same disease area. This implied the providing of legal support and strategy as well representation before the national association in the allegations (pursued by its competitor) concerning violations of the national deontological code.